Coeptis Therapeutics Inc Financial Flexibility Index
Coeptis Therapeutics Inc financial flexibility index. Coeptis Therapeutics Inc (COEP) has a Financial Flexibility Index of -0.66x as of September 2025. Free cash flow of $-2.15 Million (operating CF $-2.15 Million minus capex $3.00) represents -1% of total liabilities ($3.26 Million). See Coeptis Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Coeptis Therapeutics Inc (2004–2024)
Financial flexibility index of Coeptis Therapeutics Inc from 2004 to 2024. Historical Financial Flexibility Index trend for Coeptis Therapeutics Inc across 9 annual periods. Check cash flow quality index of Coeptis Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Coeptis Therapeutics Inc Financial Flexibility Index by Year (2004–2024)
Coeptis Therapeutics Inc financial flexibility index by year from 2004 to 2024. Year-by-year free cash flow to debt coverage for Coeptis Therapeutics Inc. For the full cash flow conversion analysis, see Coeptis Therapeutics Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.32x | $-6.65 Million | $-6.65 Million | $5.04 Million | ▼ -17.8% |
| 2023 | -1.12x | $-3.88 Million | $-3.88 Million | $3.46 Million | ▲ +10.1% |
| 2022 | -1.25x | $-3.88 Million | $-3.88 Million | $3.11 Million | ▼ -100.7% |
| 2021 | -0.62x | $-2.74 Million | $-4.49 Million | $4.41 Million | ▼ -7.7% |
| 2020 | -0.58x | $-3.14 Million | $-3.14 Million | $5.44 Million | ▲ +0.3% |
| 2019 | -0.58x | $-90.03K | $-90.07K | $155.85K | ▲ +95.7% |
| 2018 | -13.47x | $-836.27K | $-839.06K | $62.07K | ▼ -2178.3% |
| 2005 | -0.59x | $-417.02K | $-417.02K | $705.22K | ▼ -111.8% |
| 2004 | 5.00x | $1.55 Million | $1.55 Million | $310.94K | — |